EPZ-011989

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameEPZ-011989

Drug Alias NameEPZ-011989

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitors

TargetsHistone-lysine N-methyltransferase EZH2

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEpizyme Inc

China Registration ClassN/A

Active CompaniesEpizyme Inc

Inactive CompaniesN/A

Active IndicationsLymphoma, B-Cell

Inactive IndicationsN/A

ATC CodeN/A